Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Yuanyuan Qiao(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Xia Jiang(Xuzhou Medical College), Sanjana Eyunni(University of Michigan), Charles J. Zhang(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Jun Qin(Army Medical University), Abhijit Parolia(University of Michigan), Jesse W. Wotring(University of Michigan), Fengyun Su(University of Michigan), Tongchen He(University of Michigan), Rui Wang(University of Michigan), Yuping Zhang(First Affiliated Hospital of Jiangxi Medical College), Yang Zheng(Shanghai Ninth People's Hospital), Qianxiang Zhou, Yini Wang(Central South University), Caleb Cheng(University of Michigan), Honghua Yan, Liandong Ma, Carla D. Pretto(University of Michigan), Stephanie J. Ellison(University of Michigan), Jonathan Z. Sexton(University of Michigan)
Cited by 8
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k